On the evening of October 27, the public fund 2026 three-quarter report was disclosed. According to Tianxiang Investment statistics, while continuing to invest heavily in the technology sector in the third quarter, the willingness of public funds to allocate traditional assets such as consumption, pharmaceuticals, and dividends gradually increased. In terms of heavy stocks, as of the end of the third quarter of this year, Zhongji Xuchuang was still the most heavily held stock in active equity funds. The market value of its holdings was 95.9 billion yuan, and the number of fund products holding this stock reached 1,557. In addition, Xinyisheng, Yao Ming Kangde, Changxin Technology, Yuanjie Technology, Dongshan Precision, Ningde Era, Cambrian, Beifang Huachuang, and Shanghai Electric Power Co., Ltd. have also entered the active equity fund's top ten stock list. Compared to the end of the second quarter, the position of pharmaceutical stocks in public fund holdings improved markedly.

On the evening of October 27, the public fund 2026 three-quarter report was disclosed. According to Tianxiang Investment statistics, while continuing to invest heavily in the technology sector in the third quarter, the willingness of public funds to allocate traditional assets such as consumption, pharmaceuticals, and dividends gradually increased. In terms of heavy stocks, as of the end of the third quarter of this year, Zhongji Xuchuang was still the most heavily held stock in active equity funds. The market value of its holdings was 95.9 billion yuan, and the number of fund products holding this stock reached 1,557. In addition, Xinyisheng, Yao Ming Kangde, Changxin Technology, Yuanjie Technology, Dongshan Precision, Ningde Era, Cambrian, Beifang Huachuang, and Shanghai Electric Power Co., Ltd. have also entered the active equity fund's top ten stock list. Compared to the end of the second quarter, the position of pharmaceutical stocks in public fund holdings improved markedly.